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Abstract
Background: Studies have shown that type 2 diabetic patients have higher all-cause mortality than
people without diabetes, but it is less clear how diabetes affects mortality in elderly patients and to
what degree mortality differs between diabetic men and women. The aim of the present study is
to investigate the age- and sex-specific all-cause mortality pattern in patients with type 2 diabetes
in comparison with the Danish background population.
Methods: Population-based cohort study of 1323 patients, diagnosed with clinical type 2 diabetes
in 1989-92 and followed for 16 years. Median (interquartile range) age at diagnosis was 65.3 (55.8-
73.6) years. The age- and sex-specific hazard rates were estimated for the cohort using the life table
method and compared with the expected hazard rates calculated with Danish register data from
the general population.
Results: In comparison with the general population, diabetic patients had a 1.5-2.5 fold higher risk
of dying depending on age. The over-mortality was higher for men than for women. It decreased
with age in both sexes, and among patients over 80 years at diagnosis the difference between the
observed and the expected survival was small.
Conclusion:  We found an excess mortality of type 2 diabetic patients compared with the
background population in all age groups. The excess mortality was most pronounced in men and
in young patients.
Background
Studies have shown that type 2 diabetic patients have
higher all-cause mortality than people without diabetes
[1-12], but it is less clear how diabetes affects mortality in
elderly patients [13] and to what degree mortality differs
between diabetic men and women [13,14]. An increased
mortality is commonly reported in diabetic patients under
the age of 70 years at diagnosis [2,3] and in some studies
also in patients over this age [1,6,7,9]. Previous research,
however, found no increased mortality in patients over 70
years of age irrespective of sex [5] or in elderly male
patients [2,3,15] or elderly female patients [10]. This may
partly be explained by short follow-up times and few par-
ticipants which may reflect lack of power to detect a real
effect of patient's sex and age on mortality [2,5,10,15].
Furthermore, a sex-related difference in all-cause mortal-
ity may have changed over time [14] and possibly to a dif-
ferent degree in different countries [16].
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This study presents the long-term follow-up of a Danish
population-based cohort of 1323 newly diagnosed type 2
diabetic patients aged 40 years or over [10]. The aim of the
present study was to investigate the mortality patterns
over the first 16 years after diabetes diagnosis in compari-
son with the general Danish population, and to assess the
influence of age and sex.
Methods
At the end of 1988, 474 general practitioners (GPs) volun-
teered to take part in the Danish study, Diabetes Care in
General Practice [17]. Before the study started, the GPs
were randomized to an intervention and a comparison
group. All doctors were to include all patients on their
practice list fulfilling the following criteria: 1) diabetes
mellitus diagnosed from 1 March 1989 to 28 February
1991 (71 GPs volunteered for a 1-year extension of this
period to establish a large cohort of patients suitable for
epidemiological research), 2) based on hyperglycaemic
symptoms and/or raised blood glucose values measured
in general practice, the diagnosis was established by a sin-
gle fasting whole blood or plasma glucose concentration
≥7.0/8.0 mmol/l measured at a major laboratory, and 3)
age 40 years or older at diagnosis. The GPs were repeatedly
instructed not to alter diagnostic practice during the inclu-
sion period and to include all newly diagnosed patients.
Patients who were in hospital at the time of diagnosis
were also considered for inclusion in the study at their
first visit to their GP after the diagnosis. When the inclu-
sion period ended we asked the GPs how many individu-
als they had not included. Their responses revealed that
90 patients had been diagnosed but not considered for
inclusion in the trial and, of these, 40 patients would
eventually have been included if the GPs had remembered
or managed to do so. The inclusion activity was similar in
the two groups of doctors and it did not change over time
[17].
There were 358,912 subjects aged 40 years or over on the
list of patients in the participating practices by 1 March
1991 (More than 97% of the Danish population are regis-
tered with a GP in a tax-based, health insurance system)
[18]. A total of 1543 newly diagnosed diabetic patients
were eligible, but 162 were excluded because of protocol-
based exclusion criteria: life threatening somatic disease
(50), severe mental illness (50), or unwillingness to par-
ticipate (62). In addition, 46 patients treated with steroids
and 12 non-Caucasian patients were excluded from the
present analysis, giving the final sample of 1323 patients.
According to start of insulin treatment within 180 days of
diagnosis, 97.6% of the patients were considered to have
type 2 diabetes [17].
The vital status of all the diabetic patients was certified on
the 31 January 2006 through The Danish Civil Registra-
tion System http://www.cpr.dk. This is the main adminis-
trative registry in Denmark, which includes complete and
continuously updated information on all Danish resi-
dents on vital status: date of birth, and whether the person
is alive, deceased or has emigrated, along with the dates of
these events [19]. Among our cohort of patients, the vital
status for one patient could not be assessed because this
person had emigrated in 1992.
The remaining variables in Table 1 have been described
elsewhere [17].
The protocol was approved by the ethics committee of
Copenhagen and Frederiksberg.
Statistical analysis
Patients randomized to the intervention and the compar-
ison group were analysed together since the intervention
was not a significant predictor of mortality [17]. Survival
functions were estimated by a Kaplan-Meier estimator:
gender differences were tested by log-rank tests. Sex- and
age-specific (age in 5-year intervals) hazard rates for mor-
tality in the general Danish population were calculated
from national register data from the years 2001-2005 and
1991-1995 (http://www.dst.dk., data accessed June 2007)
as the average of the age-specific death intensities for the
ages in the age-group. For the cohort of diabetic patients
corresponding hazard rates were estimated using the life
table method [20], i.e. a constant death intensity was esti-
mated in each age and sex group as the number of deaths
in the group divided by the total time lived in the group;
and patients moved from one age group to the next as they
became older. Approximate 95% confidence intervals
were calculated using a normal distribution for the loga-
rithm of the estimated death intensities. The yearly sur-
vival probability over the first 16 years after diabetes
diagnosis thus estimated for the diabetic patients was
compared with the expected survival probability calcu-
lated for a sample of the general population with same
gender and age distribution as the cohort of diabetic
patients.
Results
During the follow-up period of median (interquartile
range) 15.9 (15.3-16.4) years more men (67.1%) than
women (57.5%) died (P = 0.0003). At diagnosis, women
had higher age, higher systolic blood pressure, less urinary
albumin and more favourable smoking habits than men,
but otherwise the two sexes differed little concerning risk
factors and diabetic complications (Table 1). The excess
mortality in men compared with woman was seen in all
age groups (Table 2) and seems fairly constant over time
after diagnosis (Fig. 1).BMC Public Health 2009, 9:400 http://www.biomedcentral.com/1471-2458/9/400
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In Fig. 2 and 3 the observed and expected survival are
depicted by applying the life table method, as proposed
by Lee [20]. Fig. 2 shows that the survival curve for the
male diabetic patients aged 40-79 years separates from the
corresponding curve for the Danish population immedi-
ately after diabetes diagnosis. This happens only after 3-5
years for women in the same age group (Fig. 3).
Compared with the Danish population, the diabetic
patients had an increased mortality risk during the 16
years of follow-up (Table 3, Fig. 2 and 3) and males seem
to have a slightly higher over-mortality than women
(Table 3).
The excess mortality in the cohort of patients compared
with the Danish population decreases with increasing age
in both sexes (Table 3), and among patients 80 years or
over at diagnosis the difference between the observed and
the expected survival is small (Fig. 2 and 3). As can be seen
in table 3, the relative risks are a little lower in all age
groups if we use hazard rates for mortality in the general
Danish population from the years 1991-1995 instead of
2001-2005, but our finding that the relative risk decreases
with age persists.
Discussion
In this population-based study of 1323 primarily type 2
diabetic patients followed for 16 years from the day of
Table 1: Baseline characteristics. Values are medians (interquartile ranges) or number (%)
Variable Men
n = 704
Women
n = 619
Total
n = 1323
Age at diagnosis (years) 63.6 (54.1-71.4) 67.5 (57.8-75.4) 65.3 (55.8-73.6)
Diagnostic plasma glucose (mmol/l) 13.7 (10.8-16.9) 13.7 (10.5-17.0) 13.7 (10.7-17.0)
Total cholesterol (mmol/l) 6.1 (5.2-6.9) 6.3 (5.6-7.3) 6.2 (5.4-7.1)
Triglyceride (mmol/l) 1.96 (1.38-3.01) 1.97 (1.42-2.85) 1.96 (1.40-2.91)
Systolic blood pressure (mm Hg) 144 (130-160) 155 (140-170) 150 (130-160)
Body mass index (kg/m2) 29.0 (26.3-31.7) 29.6 (26.0-33.7) 29.2 (26.2-32.8)
Urinary albumin (mg/ml) 13.3 (7.0-36.0) 9.7 (4.8-21.1) 11.6 (5.8-29.1)
Cardiovascular disease 214 (31.3) 178 (29.4) 392 (30.4)
Diabetic retinopathy 33 (5.3) 23 (4.2) 56 (4.8)
Peripheral neuropathy 139 (20.0) 112 (18.4) 251 (19.3)
Known cancer 26 (3.8) 51 (8.4) 77 (6.0)
Smoking
Never 90 (13.2) 295 (48.8) 385 (29.9)
Former 299 (43.8) 147 (24.3) 446 (34.6)
Current 294 (43.0) 163 (26.9) 457 (35.5)
Physical activity
Low 158 (23.2) 191 (31.5) 349 (27.1)
Moderate 455 (66.9) 396 (65.2) 851 (66.1)
High 67 (9.9) 20 (3.3) 87 (6.8)BMC Public Health 2009, 9:400 http://www.biomedcentral.com/1471-2458/9/400
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diagnosis, we found an excess mortality compared with
the background population in all age groups. The over-
mortality generally seemed to be higher for males than for
females and it decreased with age in both sexes.
The list-patient system in Danish general practice with a
well-defined background population in each practice, the
unchanged inclusion activity during the inclusion period,
the few exclusions and doctors' self-reports suggest that
patients in this study are likely to be a representative sam-
ple of patients aged 40 years of age or over with newly
diagnosed clinical diabetes in Denmark. Based on the
information given by the GPs, only about 5% of eligible
cases with newly diagnosed diabetes were not considered
for inclusion or primary exclusions. A relatively high pro-
portion of the oldest patients die shortly after diabetes
diagnosis, but this early mortality could have been even
greater if the GPs had included the 50 patients excluded
because of severe somatic disease. Many of these patients
were sick and dying, and the decision to exclude them was
made by the GPs mainly following ethical considerations.
Furthermore, the long-term follow up during which
almost 2/3 of the patients died strengthens the results in
this paper. Moreover, in comparison with other studies
that included patients with different diabetes duration
[21], we included only newly diagnosed patients which
minimizes the risk of selecting an artificially healthy
cohort of diabetic patients [22]. Finally, we used data
from the Danish Civil Register which enabled collection
of almost complete information on mortality over the 16-
year follow-up period. Vital status was only unknown for
one person, who emigrated.
It is a limitation that the reference population encom-
passed diabetic patients. This may have underestimated
the observed excess mortality especially among the oldest
patients where diabetes prevalence is highest (i.e. between
10-15%). We did not adjust for established risk factors for
death since this information was not available from the
reference population. Other studies, adjusting for such
risk factors, have found that the risk of death among peo-
ple with diabetes relative to those without diabetes is gen-
erally equal to or only slightly lower than the crude age-
adjusted estimate of the relative risk [14,23,24].
In accordance with mortality studies from The United
Kingdom [1,6,7], Italy [2], Germany [3], The Netherlands
[4], The United States [14], Brazil [9] and Australia [5] we
found that type 2 diabetic patients in comparison with the
general population had a 1.5-2.5 fold higher risk of mor-
Table 2: Number of deaths from diabetes diagnosis until 31 January 2005
Males Females
Age at 
Diabetes 
Diagnosis 
(years)
No. of Subjects Person-Years 
of Observation
No. of Deaths % No. of Subjects Person-Years 
of Observation
No. of Deaths %
40-44 37 520 8 21.6 26 409 1 3.9
45-49 73 1006 19 26.0 35 532 3 8.6
50-54 82 1045 35 42.7 61 844 16 26.2
55-59 89 1071 49 55.1 59 782 22 37.3
60-64 108 1089 73 67.6 79 1071 28 35.4
65-69 112 1055 91 81.3 96 1088 60 62.5
70-74 96 766 93 96.9 99 1037 76 76.8
75-79 59 381 56 94.9 97 778 83 85.6
80-85 35 169 35 100 47 278 47 100
85+ 13 52 13 100 20 92 20 100
Total 704 7154 472 67.1 619 6910 356 57.5BMC Public Health 2009, 9:400 http://www.biomedcentral.com/1471-2458/9/400
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tality depending on the age of the patients. An excess risk
of death has previously been found even for newly diag-
nosed diabetic patients in population-based studies
[3,25].
The survival curve for diabetic men aged 40-79 years sep-
arates from the corresponding curve for the Danish popu-
lation immediately after diabetes diagnosis whereas this
happens after approximately 6 years for women of the
same age showing that both female and male diabetic
patients have increased mortality risk compared with the
general population (Fig. 2 and 3). Our study, however,
indicates that in most age groups diabetic men have
higher excess risks than diabetic women (Table 3). This is
in accordance with results from Poland [26] and Japan
[27]. Recent results from the US [14] indicate that reduc-
tion in mortality rates among diabetic men has reduced
the previously observed female-over-male advantage in
mortality among diabetic patients, and the sex-difference
in mortality we observed may also have lessened in recent
years due to a faster decrease in the mortality rate among
Danish male diabetic patients relatively to female patients
[21]. Our results are, however, contrary to other popula-
tion-based studies where female diabetic patients
[2,7,8,15] and especially relatively young women [1,5,6]
are often seen to have greater excess mortality than men.
To a certain degree our results may be explained by the
observed high general mortality of women relative to men
when Denmark is compared with other Western-Euro-
pean countries http://www.who.int. As can be seen from
Table 1, it does not seem that our female patients in com-
parison with men have less severe diabetes or lower risk
factor levels at diagnosis.
Observed and expected survival curve of newly-diagnosed  diabetic patients up to 16 years after diabetes diagnosis Figure 3
Observed and expected survival curve of newly-diag-
nosed diabetic patients up to 16 years after diabetes 
diagnosis. Females, life table method, diabetic patients: — 
(blue), 95% confidence intervals shown, Danish population: --
---- (red).
Survival of diabetic patients after diabetes diagnosis according  to gender and age at diagnosis Figure 1
Survival of diabetic patients after diabetes diagnosis 
according to gender and age at diagnosis. Kaplan-Meier 
curves. Males: ------ (red). Females: — (blue). Log-rank test, p 
= 0.0003 (age 40-59 years), p < 0.0001 (age 60-79 years), p = 
0.2984 (age ≥80 years).
Observed and expected survival curve of newly-diagnosed  diabetic patients up to 16 years after diabetes diagnosis Figure 2
Observed and expected survival curve of newly-diag-
nosed diabetic patients up to 16 years after diabetes 
diagnosis. Men, life table method, diabetic patients: — 
(blue), 95% confidence intervals shown, Danish population: --
---- (red).BMC Public Health 2009, 9:400 http://www.biomedcentral.com/1471-2458/9/400
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Table 3: Hazard rates during the first 16 years after diabetes diagnosis as compared with the Danish Population
Age at Time of 
Death (years)
Diabetic Patients Danish population Relative risk 
(2001-05) ‡
Relative risk 
(1991-95) λ
No. of Deaths Hazard Rate* (95% 
Confidence 
Interval)
Hazard rate 
(2001-05)†
Hazard rate 
(1991-95)φ
Males
40-44 3 40.0 (12.9-124.0) 2.3 3.0 17.7 14.4
45-49 3 9.0 (2.9-28.0) 3.8 4.3 2.4 2.1
50-54 11 15.6 (8.7-28.2) 6.0 6.7 2.6 2.3
55-59 23 22.7 (15.1-34.1) 9.0 11.5 2.5 2.0
60-64 45 39.4 (29.4-52.8) 14.2 19.2 2.8 2.1
65-69 64 54.8 (42.9-70.1) 23.3 30.6 2.4 1.8
70-74 77 69.2 (55.3-86.5) 38.2 48.6 1.8 1.4
75-79 85 95.0 (76.8-117.5) 62.6 74.3 1.5 1.3
80-85 92 184.1 (150.1-225.8) 101.5 113.1 1.8 1.6
85+§ 52 265.9 (202.7-349.0)
Total 455 63.7 (58.1-69.9)
Females
40-44 0 0.0 (0.0-0.4) 1.3 1.8 0.0 0.0
45-49 0 0.0 (0.0-0.1) 2.4 2.9 0.0 0.0
50-54 4 9.3 (3.5-24.9) 3.8 4.7 2.5 2.0
55-59 10 14.5 (7.8-27.0) 5.8 7.6 2.5 1.9
60-64 13 15.3 (8.9-26.3) 9.2 12.3 1.7 1.3
65-69 22 21.9 (14.4-33.2) 15.4 18.5 1.4 1.2
70-74 41 36.9 (27.2-50.1) 25.8 28.4 1.4 1.3
75-79 68 60.0 (47.3-76.1) 40.6 44.3 1.5 1.4
80-85 86 95.7 (77.5-118.2) 67.2 74.9 1.4 1.3
85+§ 75 171.6 (136.9-215.2)
Total 319 46.7 (41.8-52.1)
*Hazard rates (×1000) estimated as number of deaths divided by person years of observation.
†Hazard rates (×1000) estimated as average mortality rates from the life table 2001-2005 of the Danish population.
φ Hazard rates (×1000) estimated as average mortality rates from the life table 1991-1995 of the Danish population
‡This is calculated by dividing the hazard rate of diabetic patients by the hazard rate of the Danish population (2001-2005).
λ This is calculated by dividing the hazard rate of diabetic patients by the hazard rate of the Danish population (1991-1995).
§Among subjects aged 85 years or over, the age distribution for diabetic patients is very different from that of the background population. Therefore, a 
comparable hazard rate for the background population cannot be calculatedBMC Public Health 2009, 9:400 http://www.biomedcentral.com/1471-2458/9/400
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The relatively small number of deaths in people under 50
and over 80 years gives the estimated hazard rates and sur-
vival probabilities in these age groups wide confidence
intervals (Table 3, Fig. 2 and 3). Although mortality in the
general Danish population decreased during the period of
the study, our results demonstrate that the excess mortal-
ity is highest among the youngest patients and decreases
with increasing age in both sexes (Table 3). This is in
accordance with most previous studies [1-3,6,8,9] includ-
ing a Danish diabetes register based study [21] recognis-
ing this study included both type 1 and type 2 diabetic
patients and probably did not encompass all newly diag-
nosed patients in Denmark. Even though our cohort of
patients were recruited in 1989-92, and the mortality gap
between diabetic patients and the general population may
have lessened in recent years it does not seem to have dis-
appeared [13,21]. As can be seen in figure 1, mortality
rates are relatively constant over time for men and women
in the three age groups. Therefore, we think that the find-
ing of a lower relative risk of dying among the higher age
groups compared to patients in the lower age groups is
not due to a survivor effect, i.e. that surviving patients
have a lower probability of dying, than newly diagnosed
patients of the same age.
The excess mortality extends even to the old patients up to
80 years of age (Table 3, Fig. 2 and 3). Similar results were
found in other studies with a large number of elderly dia-
betics [1,6,21] but our results are in contrast to other stud-
ies which showed no increased mortality for those
diagnosed after 70-75 years of age [2,3,5,15]. These stud-
ies may reflect survival bias as pointed out earlier or too
little power to show a real effect of age on mortality. Our
results support that preventive treatment is advisable also
for the old patients with respect for their personal values,
motivation, capabilities and co-morbidities [28,29].
Conclusion
We found that the diagnosis of diabetes gives an increased
all-cause mortality risk in both men and women with type
2 diabetes, but men had a higher over-mortality than
women. Although the excess risk of dying persisted in the
old patients of both sexes it was most prominent in the
youngest age groups.
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